KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Notes Payables (2016 - 2025)

Johnson & Johnson's Notes Payables history spans 17 years, with the latest figure at $8.5 billion for Q4 2025.

  • For Q4 2025, Notes Payables rose 41.99% year-over-year to $8.5 billion; the TTM value through Dec 2025 reached $8.5 billion, up 41.99%, while the annual FY2025 figure was $8.5 billion, 41.99% up from the prior year.
  • Notes Payables for Q4 2025 was $8.5 billion at Johnson & Johnson, up from $6.4 billion in the prior quarter.
  • Across five years, Notes Payables topped out at $18.0 billion in Q2 2023 and bottomed at $2.6 billion in Q1 2021.
  • The 5-year median for Notes Payables is $4.5 billion (2024), against an average of $7.1 billion.
  • The largest YoY upside for Notes Payables was 318.41% in 2023 against a maximum downside of 72.95% in 2023.
  • A 5-year view of Notes Payables shows it stood at $3.8 billion in 2021, then grew by 16.48% to $4.4 billion in 2022, then decreased by 21.99% to $3.5 billion in 2023, then soared by 73.37% to $6.0 billion in 2024, then surged by 41.99% to $8.5 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Notes Payables are $8.5 billion (Q4 2025), $6.4 billion (Q3 2025), and $11.5 billion (Q2 2025).